We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo.
- Authors
Cantisani, Carmen; Cantoresi, Franca; Mercuri, Santo Raffaele; Binic, Iva; Golubovic, Masa; Marino, Raffaella; Paolino, Giovanni
- Abstract
Topical imiquimod therapy has proven to be effective for a variety of infectious, neoplastic, and inflammatory dermatologic diseases; in this regard, Metcalf, Crowson, Naylor, Haque, and Cornelison ([1]) showed reparative changes to the epidermis and the dermal collagen bundles in chronically sun-damaged skin, indicating also its potential use as an antiaging treatment. The patient was instructed to apply imiquimod 3.75% cream once daily (2-week treatment cycles separated by a 2-week no-treatment interval), with a follow-up period of 8 weeks. Finally, topical imiquimod 3.75% cream has an acceptable tolerability profile, with an easy treatment regimen and elderly patients may find the once-daily treatment regimen easier to adhere than more frequent regimens (Stockfleth, [4]).
- Subjects
IMIQUIMOD; OINTMENTS; LENTIGO
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 2, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.13256